SBIA
ARNA

Sheaff Brock Investment Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,000
Closed -$18K – 660
2016
Q3 		$18K Buy
+1,000
New +$16.6K ﹤0.01% 553

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Sheaff Brock Investment Advisors's ARNA Position: Q4 2016 in Review

Sheaff Brock Investment Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2016, closing a stake of 1,000 shares — an estimated $18K sold.

Sheaff Brock Investment Advisors first reported a position in ARNA in Q3 2016 and held it in 1 quarter. The position peaked at $18K in Q3 2016. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.

  • Sheaff Brock Investment Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 1,000 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $18K.
  • Sheaff Brock Investment Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2016 and held it in 1 quarter.
  • Sheaff Brock Investment Advisors's Arena Pharmaceuticals Inc position peaked at $18K in Q3 2016.
  • 128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.